Generate Biomedicines, Inc. (GENB) News
Follow Generate Biomedicines, Inc. (GENB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Form SCHEDULE 13G Generate Biomedicines, Filed by: FMR LLC
Filed on: November 5, 20
EQUITY | Nov 05, 2026, 06:17 PM UTC
M
Generate Biomedicines Signs Zealand Pharma Collaboration Worth Up to Nearly $1.2 Billion
Generate Biomedicines will design AI-engineered protein therapeutics for metabolic diseases with Zealand Pharma. The deal includes $30 million upfront, up to $35 million in early preclinical milestones, and eligibility f
EQUITY | Oct 13, 2026, 08:38 PM UTC
L
Generate Biomedicines and Zealand Pharma enter collaboration and license agreement
The agreement covers development of AI-engineered protein therapeutics for metabolic diseases.
EQUITY | Oct 13, 2026, 08:32 PM UTC
L
HC Wainwright maintains $30.00/share Biomedicines price target
HC Wainwright & Co. maintained its price target of $30.00 per share on Generate Biomedicines, according to Benzinga ratings actions.
EQUITY | Sep 08, 2026, 04:05 PM UTC
L
Generate Biomedicines to participate in September investor conferences
Generate Biomedicines Inc. plans to participate in September investor conferences.
EQUITY | Sep 08, 2026, 11:09 AM UTC
L
HC Wainwright maintains Generate Biomedicines Buy rating
HC Wainwright & Co. maintained its Buy rating on Generate Biomedicines.
EQUITY | Aug 28, 2026, 10:17 AM UTC
L
GENB - Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
GENB - Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
EARNINGS | Aug 06, 2026, 11:00 AM UTC
H
Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Wednesday. Shares of Nike Inc (NYSE: NKE ) fell sharply in pre-market trading after the company reported fourth-quarter res
EARNINGS | Jul 01, 2026, 12:02 PM UTC
H
Why Constellation Brands Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Constellation Brands Inc (NYSE: STZ ) rose sharply in pre-market trading after the company reported upbeat first-quarter financial results and raised its FY27 earnings guidance. Constellation Brands reported qu
EARNINGS | Jul 01, 2026, 09:10 AM UTC
L
GENB: Signs Lease
GENB's AdvanCell signs 128,000 square foot lease at IQHQ's Innovation Park in Andover, Massachusetts
EQUITY | Jun 22, 2026, 12:03 PM UTC